Predictive factors and a corresponding treatment algorithm for controlled ovarian stimulation in patients treated with recombinant human follicle stimulating hormone (follitropin alfa) during assisted reproduction technology (ART) procedures. An analysis of 1378 patients

By Howles C. M.   Saunders H.   Alam V.   Engrand P.    

Current Medical Research and Opinion, Vol. 22, Iss. 5, 2006-05 ,pp. : 907-918

Informa Healthcare

Access to resources Recommend Favorite

Treatment of idiopathic oligozoospermia with recombinant human follicle‐stimulating hormone: a prospective, randomized, double‐blind, placebo‐controlled clinical study in Chinese population

By  

CLINICAL ENDOCRINOLOGY, Vol. 83, Iss. 6, 2015-12 ,pp. : 866-871

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bioequivalence of liquid and freeze-dried recombinant human follicle-stimulating hormone

By Lugan I.   Febbraro S.   Lecuelle H.   Papasouliotis O.   Ho-Nguyen Q.   Buraglio M.  

Current Medical Research and Opinion, Vol. 21, Iss. 1, 2005-01 ,pp. : 121-125

Informa Healthcare

Access to resources Recommend Favorite

Use of follicle-stimulating hormone for the treatment of female infertility – current concepts

By Pang Samuel C  

Women's Health, Vol. 1, Iss. 1, 2005-07 ,pp. : 87-95

Future Medicine

Access to resources Recommend Favorite

Low density lipoprotein receptor relatives in chicken ovarian follicle and oocyte development

By  

Cytogenetic and Genome Research, Vol. 117, Iss. 1-4, 2007-08 ,pp. : 248-255

Karger

Access to resources Recommend Favorite